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ARTICLE
Phosphoinositide 3-Kinase Binds to TRPV1 and Mediates 
NGF-stimulated TRPV1 Trafﬁ  cking to the Plasma Membrane
Alexander T. Stein,1 Carmen A. Ufret-Vincenty,2 Li Hua,2 Luis F. Santana,2 
and Sharona E. Gordon2
1Graduate Program in Neurobiology and Behavior and 2Department of Physiology and Biophysics, University of Washington, 
Seattle, WA 98195
Sensitization of the pain-transducing ion channel TRPV1 underlies thermal hyperalgesia by proalgesic agents such 
as nerve growth factor (NGF). The currently accepted model is that the NGF-mediated increase in TRPV1 function 
during hyperalgesia utilizes activation of phospholipase C (PLC) to cleave PIP2, proposed to tonically inhibit 
TRPV1. In this study, we tested the PLC model and found two lines of evidence that directly challenge its validity: 
(1) polylysine, a cationic phosphoinositide sequestering agent, inhibited TRPV1 instead of potentiating it, and (2) 
direct application of PIP2 to inside-out excised patches dramatically potentiated TRPV1. Furthermore, we show 
four types of experiments indicating that PI3K is physically and functionally coupled to TRPV1: (1) the p85β sub-
unit of PI3K interacted with the N-terminal region of TRPV1 in yeast 2-hybrid experiments, (2) PI3K-p85β coim-
munoprecipitated with TRPV1 from both HEK293 cells and dorsal root ganglia (DRG) neurons, (3) TRPV1 
interacted with recombinant PI3K-p85 in vitro, and (4) wortmannin, a specifi  c inhibitor of PI3K, completely abol-
ished NGF-mediated sensitization in acutely dissociated DRG neurons. Finally, simultaneous electrophysiological 
and total internal refl  ection fl  uorescence (TIRF) microscopy recordings demonstrate that NGF increased the 
number of channels in the plasma membrane. We propose a new model for NGF-mediated hyperalgesia in which 
physical coupling of TRPV1 and PI3K in a signal transduction complex facilitates traffi  cking of TRPV1 to the 
plasma membrane.
INTRODUCTION
Painful thermal and chemical stimuli directly gate the 
cation channel, TRPV1, which is expressed in neurons 
with cell bodies in dorsal root ganglia (DRG) and tri-
geminal ganglia (Caterina et al., 1997). Activation of 
TRPV1 channels produces an infl  ux of Na+, which de-
polarizes the neurons, and Ca2+, which acts as a second 
messenger with pleiotropic downstream effects. TRPV1 
is activated by several agents: temperatures >42°C; ex-
tracellular protons, with a pKa of 5.5; anandamide and 
arachidonic acid metabolites; and capsaicin, the pun-
gent extract from hot chili peppers (for reviews see 
  Caterina and Julius, 2001; Julius and Basbaum, 2001). 
The importance of TRPV1 in nociception is demon-
strated by a study with TRPV1 knockout mice (Caterina 
et al., 2000). In contrast to wild-type mice, TRPV1 
knockout mice drank capsaicin-laced water freely, their 
responses to painful heat were impaired, and they 
showed little infl   ammation-induced hyperalgesia. At 
the cellular level, cultured DRG neurons from TRPV1 
knockout mice were insensitive to capsaicin, heat, and 
extracellular acidifi  cation. Thus, TRPV1 is an essential 
element in detecting painful thermal and chemical stim-
uli and a potential target for clinical agents to reduce 
debilitating pain.
Infl  ammatory pain is an increasingly prevalent prob-
lem in our aging population, and the common thera-
pies (opiates and COX-2 inhibitors) are suboptimal in 
both safety and effi  cacy. Understanding infl  ammatory 
pain at the level of nociceptors is required in order to 
develop more effective therapies. The excitability of 
  peripheral nociceptors is modulated by G protein–
  coupled receptors (GPCRs) and receptor tyrosine kinases 
(RTKs), which are proposed to sensitize gating of 
TRPV1 (Cortright and Szallasi, 2004; Suh and Oh, 
2005). However, the mechanism by which GPCR and 
RTK ligands sensitize TRPV1 is unclear.
Nerve growth factor (NGF) is released onto peripheral 
nerve endings during infl  ammation (Shu and Mendell, 
1999b) and may be retrogradely transported to act 
at nociceptor cells bodies in the dorsal root ganglia 
(Campenot and MacInnis, 2004). NGF has been impli-
cated in both diminishing the magnitude of Ca2+-
  dependent desensitization (Galoyan et al., 2003) and 
sensitizing TRPV1 in a Ca2+-independent manner (Shu 
and Mendell, 1999a, 2001; Galoyan et al., 2003). NGF 
activates a receptor tyrosine kinase, trkA. trkA can, in 
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turn, be coupled to three pathways: PLC, PI3K, and 
MAPK (Wiesmann and de Vos, 2001). In the generally 
accepted PLC model of hyperalgesia (Chuang et al., 
2001; Prescott and Julius, 2003), binding of NGF to trkA 
is coupled to PLC activation. PLC then hydrolyzes PIP2 
to sensitize TRPV1 (Fig. 1, bottom left). Hydrolysis of 
PIP2 would sensitize TRPV1 because PIP2 is believed to 
tonically inhibit TRPV1. Inhibition of TRPV1 by PIP2 is 
proposed to be mediated by direct binding of PIP2 to a 
site near the C terminus of TRPV1: deletion of this site 
has been found to eliminate sensitization of TRPV1 by 
NGF (Prescott and Julius, 2003; Zhang et al., 2005a).
More recent results indicate that TRPV1 sensitization 
by NGF may not be due solely to PIP2 cleavage by PLC. 
Two groups found that inhibitors of PI3K, but not of 
PLC, were effective in blocking NGF-mediated sensiti-
zation in dissociated DRG neurons (Bonnington and 
  McNaughton, 2003; Zhuang et al., 2004). PI3K inhibitors 
similarly blocked NGF sensitization in a mouse hyperal-
gesia behavioral test (Zhuang et al., 2004). Finally, acti-
vation of p38 MAPK has been shown to act downstream 
of NGF/trkA to increase the protein levels of TRPV1 in 
nociceptor terminals in a transcription-independent 
manner (Ji et al., 2002). These results raise the question 
of whether TRPV1 sensitization by NGF is mediated by 
both the PLC and PI3K pathways and whether PIP2 
plays a role in modulating TRPV1. In this study we have 
directly tested the PLC model for NGF-mediated sensi-
tization. Here we show that, in contrast to predictions of 
the PLC model, PIP2 potentiates TRPV1. We further 
demonstrate that PI3K is physically associated with 
TRPV1 in a signal transduction complex, PI3K activity is 
required for NGF-mediated sensitization, and sensitiza-
tion consists of an increase in the number of channels 
in the plasma membrane.
MATERIALS AND METHODS
Yeast-2-Hybrid
A pretransformed M  A  T  C  H  M  A  K  E  R   fetal human brain cDNA li-
brary in yeast strain Y187 was purchased from CLONTECH Labo-
ratories, Inc. (HY4028AHpACT2). TRPV1 N1-432 was subcloned 
into the pGBKT7 GAL4DNA-BD vector (CLONTECH Laborato-
ries, Inc.). Y187-compatible mating strain AH109 was transformed 
with TRPV1 N1-432-GAL4DNA-BD. Library screening was per-
formed by mating. Diploid yeast were plated onto SD/−His/
−Leu/−Trp (2% agar, 0.67% yeast N2 base, 20 mg/liter l-ade, 
20 mg/liter l-arg, 30 mg/liter l-iso, 30 mg/liter l-lys, 20 mg/liter 
l-met, 50 mg/liter l-phe, 200 mg/liter l-thr, 30 mg/liter l-tyr, 150 
mg/liter l-val) + 3 mM 3-AT to select for diploid colonies ex-
pressing the HIS3 reporter. Positive colonies were identifi  ed by 
DNA sequencing, and confi  rmed by directed 2-hybrid screening 
of cotransformants.
Cell Culture
HEK293 cells were cultured in DMEM + 10% FBS, 0.3 mM l-glu-
tamine, 0.1 mM nonessential amino acids, and 50 U/ml penicillin 
with 50 μg/ml streptomycin at 37°C, 5% CO2. F-11 cells were cul-
tured in F12 medium + 20% FBS, 0.2 mM l-glutamine, 100 μM 
sodium hypoxanthine, 400 nM aminopterin, 16 μM thymidine 
(HAT supplement), and penicillin/streptomycin at 37°C, 5% CO2. 
Cells were transfected with Lipofectamine 2000 or Lipofectamine 
(Invitrogen) according to the manufacturer’s instructions. Cells 
were used for electrophysiology on the day after transfection. 
Cells were used for biochemistry 1–3 d after transfection.
DRG neurons were isolated by manual dissection. C57BL/6 
mice were anaesthetized with halothane, decapitated, and their 
spinal columns were removed. The spinal column was bisected 
and whole ganglia were excised from the surrounding tissue into 
Hank’s buffered saline solution (HBSS). Ganglia were digested 
with 20 U/ml papain in papain-activation solution (100 mg/ml 
l-cys, 0.25 mM EDTA, 375 μM CaCl2, HBSS pH 7.4 with NaHCO3), 
and then collagenase/dispase (1 mg/ml collagenase, 1 mg/ml 
dispase II in HBSS). Neurons were dissociated from digested 
ganglia by manual trituration with a fi  re-polished, serum-coated 
glass pipette. Finally, neurons were resuspended in F12 medium 
+ 10% FBS and plated in a small volume onto glass coverslips 
coated with 20 μg/ml laminin and 20 μg/ml polylysine. After 5 h, 
the neurons were immersed in fresh medium. Neurons were 
used for electrophysiology between 5 and 12 h after dissection. 
Neuronal death due to NGF deprivation was not observed during 
this time.
Immunoprecipitations
Proteins were extracted for immunoblotting from DRG neurons 
by cell lysis with DRG lysis buffer (PBS with HALT protease inhibi-
tor cocktail [Pierce Chemical Co.]). An appropriate antibody was 
added to the lysate and was incubated for minimum of 2 h on a 
shaker at 4°C. Antibody/protein complexes were then bound to 
protein G agarose beads using a batch method. The beads were 
washed three to fi  ve times with 1 ml ice cold protein G binding 
buffer (0.01 M sodium phosphate, pH 7.0, 0.15 M sodium chlo-
ride) with 0.1% Triton X-100. Proteins were eluted with laemmli 
sample buffer + 5% β-mercaptoethanol for gel electrophore-
sis. We obtained the anti–PI3K-p85β antibody from Abcam, the 
anti-pan trk antibody from Santa Cruz, the anti-phosphotyrosine 
antibody from Cell Signaling Technology and the anti-TRPV1 
antibody (anti–N-term antibody) used for immunoblotting from 
Neuromics. For immunoprecipitation we used a custom-made an-
tibody (Covance) raised in rabbits against the sequence C  Y  T  G  S  L-
K  P  E  D  A  E  V  F  K  D  S  M  V  P  G  E  K   and affi  nity purifi  ed with the Sulfolink 
Kit (Pierce Chemical Co.).
HEK293 cell lysates were prepared by solubilization of cul-
tured cells in digitonin buffer (20 mM triethanolamine, pH 
8.0, 300 mM NaCl, 2 mM EDTA, 20% glycerol, 1% digitonin + 
protease inhibitors). Proteins were immunoprecipitated with 
anti-FLAG M2-agarose beads (Sigma-Aldrich), and eluted with 
laemmli + 5% β-mercaptoethanol. Proteins were separated by 
gel electrophoresis and transferred to PVDF membranes. For 
Western blotting, the membranes were blocked for 1 h in TBS-T 
pH 7.6 (20 mM Tris, 137 mM NaCl, 3.8 mM HCl, 0.1% Tween 20) 
with 5% (wt/vol) milk. Primary antibody was diluted according 
to manufacturer’s instruction in TBS-T + milk and the second-
ary antibody was diluted in TBS-T. Membranes were developed 
using SuperSignal West Femto Max Sensitivity Substrate (Pierce 
Chemical Co.) and images obtained using a FluorChem 8000 
(Alpha Innotech).
Protein Interaction Assays
PI3K p85α and its domains, except C-SH2, were provided by 
L. Cantley (Harvard University, Cambridge, MA) as follows: p85α.
pGEX-1 Lambda T; N-SH2.pGEX-3X; SH3.pGEX-4T-2; and BCR.
pGEX-5X-3. C-SH2 was constructed through PCR using p85α.
pGEX-1 Lambda T as a template and oligos (5′-G  A T  G  G  G  A T  C  C  C  C-
T A  C  T  G  G  G  G  A  G  -3′ and 5′-G  A  G  C  T A  G  G  A  A T  T  C  T  T A  C  C  G  G  T A  G  T-
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N1-432-FLAG.pGEX-6X-1 and all of the above constructs were 
expressed in the BL21 strain of Escherichia coli as previously de-
scribed (Rosenbaum et al., 2004). After the centrifugation of the 
overnight cultures at 4,000 rpm for 30 min in 4°C, the pellets were 
resuspended in LBBA buffer (30 mM HEPES, 500 mM NaCl, 20% 
glycerol, 1 mM DTT, 0.1 mM PMSF, 2.5 μg/ml DNase) for GSTrap 
FF purifi  cation with an AKTA Prime (GE Healthcare). Full-length 
PI3K p85α was then further purifi  ed by size exclusion chromatog-
raphy (Superdex 200 HR10-30) with an AKTA Explorer (GE 
Healthcare). GST was cleaved from TRPV1 N1-432-FLAG using 
PreScission Protease and eluted from the GSTrap FF column. For 
the rest of the GST fusion proteins, the induction was performed 
at 37°C and the cultures were grown until OD600 reached  1.5. 
The pellet from culture was resuspended in PBS with EDTA free-
Mini Protease Inhibitor Cocktail Tablets Complete (Roche Ap-
plied Science) and 1 mM DTT. The resuspended cells were lysed 
either by sonication or using an Emulsifl  ex C-5 (Avestin) and 
were incubated on a shaker at 4°C for 30 min in the presence of 
0.1% Triton X-100. After centrifugation, supernatant was incu-
bated with glutathione-agarose in PBS with 1 mM DTT for 30 min 
on a shaker at room temperature. After the incubation, the beads 
were washed extensively with PBS + 1 mM DTT + 0.1% Triton X-
100, and the proteins were eluted in GST elution buffer (50 mM 
Tris pH 8.0, 15 mM glutathione, 0.1% Triton X-100, 1 mM DTT).
TRPV1-FLAG synthesis was performed by transfection and digi-
tonin lysing of HEK293 cells as previously described (Rosenbaum 
et al., 2004). Both TRPV1-FLAG and TRPV1 N1-432-FLAG were 
bound to anti-FLAG M2 agarose beads by incubating a minimum of 
2 h at 4°C on a shaker. The beads were washed thoroughly to elimi-
nate any unbound FLAG-tagged protein. The beads were then in-
cubated for a minimum of 2 h at 4°C on a shaker in excess with GST 
fusion proteins. Beads were then washed extensively with PBS + 
0.1% Triton, and the bound material was eluted with laemmli + 
5% β-mercaptoethanol. Bound proteins and input material were 
boiled for 5 min and then separated by gel electrophoresis, trans-
ferred to PVDF membranes, and detected with anti-GST antibody.
Electrophysiology
Excised inside-out patches were obtained with fi  lamented borosil-
icate glass pipettes (Sutter BF150-86-10) and heat polished with a 
micro forge. Pipettes used for patching F-11 cells had a resistance 
of 1.2–2.5 MΩ. DRG neurons were patched with 2.5–3.5 MΩ pi-
pettes. Symmetrical calcium-free recording solutions (130 mM 
NaCl, 200 μM EDTA, 3 mM HEPES, pH 7.2) were used in the 
bath and the pipette. Patches that showed a signifi  cant time-de-
pendent loss or increase of capsaicin-induced current were dis-
carded. Patches were voltage clamped and currents recorded with 
an Axopatch 200B amplifi  er (Axon Instruments, Inc.) interfaced 
with a Dell personal computer operating Pulse v. 8.53 (HEKA 
Elektronik). Capsaicin was applied directly to the patch by an 
RSC-200 solution exchange manifold (Biologik). Because capsa-
icin freely equilibrates across the membrane, it could be applied 
to the intracellular surface of excised patches and to the extracel-
lular surface in perforated patch recordings. Its binding site, how-
ever, is believed to be located intracellularly (Jung et al., 1999). 
Because our perfusion system was designed for large amounts of 
solution (>5 ml), we used an alternative, though slower, means of 
applying PIP2. Using a glass pipette to manually fl  ush our 300-μl 
bath allowed us to use much smaller volumes of this very expen-
sive reagent. The longer bath exchange time of this method ac-
counts for the delay between PIP2 introduction and current 
potentiation observed in Fig. 2 B. All experiments were per-
formed at room temperature.
Perforated-patch recordings of DRG neurons were performed 
using fi  lamented borosilicate glass pipettes (3.0–4.0 MΩ) contain-
ing intracellular saline solution (110 mM K-aspartate, 30 mM KCl, 
10 mM NaCl, 1 mM MgCl2, 50 μM EGTA, 10 mM HEPES, pH 7.2) 
with amphoterecin B (1 mg/ml; Sigma-Aldrich). Cells were con-
tinuously perfused with calcium-free bath solution (145 mM 
NaCl, 5 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 10 mM glucose, 10 
mM HEPES, pH 7.4) + 0.1% BSA. BSA was not used in total inter-
nal refl  ection fl  uorescence (TIRF) microscopy experiments due 
to its interference with image clarity. For wortmannin experi-
ments, the cells were preincubated with wortmannin for 5 min 
before recording the initial currents measured in Fig. 6. Currents 
were recorded with either an Axopatch 200B amplifi  er or an EPC 
10 amplifi  er (HEKA Elektronik) interfaced to a Dell personal 
computer operating Pulse v. 8.53. All solutions were applied to 
the cell with an RSC-200 solution exchange manifold.
Phosphoinositide (4,5)-Bisphosphate
DiC16-PIP2 (Echelon Biosciences) was solubilized in tetrahydro-
furan:water (4:1), dried under N2, and resuspended to a stock 
concentration of 0.5 mM in water by bath sonication for 45 min. 
Stocks were divided into aliquots and frozen at −80°C. Working 
solutions were prepared daily by dilution of stock aliquots fol-
lowed by bath sonication for 40 min. DiC8-PIP2 (Echelon Biosci-
ences) was solubilized in water as a 2.5 mM stock, frozen at −20°C, 
and used the same day it was diluted from the stock.
Total Internal Reﬂ  ection Fluorescence Microscopy (TIRF)
F-11 cells were grown on glass coverslips and transfected with 
TRPV1-eYFP, trkA, and p75. At the time of the experiments, cov-
erslips were transferred to a custom-made open perfusion cham-
ber that allowed us to simultaneously perform perforated-patch 
voltage clamp. Images (100 ms exposure) were acquired using a 
through-the-lens Olympus IX-70 microscope equipped with a 
60× oil immersion PlanApo lens (numerical aperture = 1.45) 
and either a Stanford Photonics XR Mega 10 intensifi  ed charge-
coupled device camera or an Andor iXON camera (Navedo et al., 
2005, 2006). We excited eYFP using the 488-nm line of an argon 
laser. Excitation and emission light were separated using a 500-
nm long-pass dichroic mirror. An emission 530-nm band pass fi  l-
ter was placed in front of the camera.
Constant laser intensity, focus, and camera gain were main-
tained during each experiment. For analysis, we included only 
cells that did not undergo any measurable migration, displace-
ment, or movement during experiments. The spatially averaged 
fl  uorescence intensity (i.e., averaged over the entire region of the 
cell imaged) was determined using Image J software (http://rsb.
info.nih.gov/ij/) and custom software written in IDL language.
Data Analysis
All data were analyzed with Igor Pro. For bar graphs, the height of 
the bar gives the mean. Errors given in the text and error bars 
shown in all fi  gures represent the SEM. For electrophysiological 
measurements, all currents shown are difference currents, in 
which the current in the absence of capsaicin was subtracted to 
yield the capsaicin-activated component of the current.
Saturating capsaicin–response current records were prepared 
for nonstationary noise analysis by fi  tting the rising phase of the   
response with a smoothed function of the mean current. The 
smoothed current was subtracted from the raw current trace, and 
the variance was calculated from the subtracted trace. The vari-
ance was then plotted versus the smoothed function of the mean 
and fi  tted with the equation σ2 = xi − (x2)/N, where σ2 is the 
variance, x is the mean capsaicin-activated current, i is the unitary 
channel current, and N is the number of functional channels. 
The unitary conductance from the fi  t was verifi  ed by fi  tting the 
slow rising phase of a subsaturating concentration of capsaicin 
with the same function. Although this second method could not 
be used to obtain a reliable estimate of N, it yielded values of i that 
were nearly identical to those estimated from the saturating cur-
rent responses.512 PI3K-TRPV1 Complex Mediates NGF Sensitization
RESULTS
PIP2 Is a Potentiator of TRPV1, Not an Inhibitor
In the PLC model of NGF-mediated sensitization of 
TRPV1, PIP2 inhibits TRPV1 and hydrolysis of PIP2 by 
PLC relieves that inhibition (Fig. 1, bottom left). Im-
portant predictions of this model are that decreasing 
the concentration of PIP2 in the membrane will poten-
tiate TRPV1 and increasing the concentration of PIP2 
will inhibit TRPV1. We tested these predictions using 
the inside-out confi  guration of the patch-clamp tech-
nique to allow direct solution access to the intracellular 
leafl  et of the plasma membrane. We used an F-11 cell 
expression system to mimic native DRG neurons. F-11 
cells were constructed as hybridomas of mouse neuro-
blastoma (N18TG2) and rat dorsal root ganglion cells 
and they have been found to preserve many properties 
of DRG neurons (Francel et al., 1987; Jahnel et al., 
2001). In addition, expression of fl  uorescent TRPV1 
appeared reticulate in HEK293 cells but was primarily 
localized to the plasma membrane in F-11 cells (Jahnel 
et al., 2001).
To test whether decreasing the PIP2 concentration 
would potentiate TRPV1, we used polylysine to seques-
ter acidic lipids in the membrane (Rohacs et al., 2002). 
We held the patches at 0 mV and used pulses to +80 
mV to drive current through the open channels. Appli-
cation of 100 nM capsaicin to the bath activated large, 
stable currents. Although the PLC model predicts that 
polylysine will potentiate TRPV1, we found that 30 
μg/ml polylysine inhibited the capsaicin-activated cur-
rents (Fig. 2 A). The mean reduction of current was 
82% (±3%, n = 7). The inhibition was not reversed 
by extensive washing of patches with polylysine-free 
  solutions during the time course of our experiments 
(the inhibition was reversed by adding exogenous PIP2; 
see below).
We next applied PIP2 to the intracellular surface of 
the patches to ask whether it acts as an inhibitor, as 
suggested by the PLC model, or as a potentiator, as 
would be expected from the inhibition observed with 
polylysine. We found that 10 μM DiC16-PIP2 (PIP2) 
profoundly potentiated the capsaicin-activated current 
(Fig. 2 B), giving a 46-fold increase in current (±35; 
n = 5). The potentiation reversed partially over tens 
of minutes, as though PLC or lipid phosphatases were 
active in the patch. (Note that the different perfusion 
mechanism used for this experiment produced the de-
layed onset of potentiation observed in Fig. 2 B; see 
Materials and methods.) No change in current ampli-
tude was observed in untransfected F-11 cells treated 
with PIP2 (n = 5; Fig. 2 C). A soluble, short-chain PIP2 
(DiC8-PIP2) induced potentiation that was rapidly re-
versed upon removal of DiC8-PIP2 from the bath (Fig. 
2 D). Finally, the general TRP channel blocker ruthe-
nium red (RR; 10 μM) blocked the same fraction of the 
capsaicin-activated current in the presence and absence 
of PIP2 (IRR/I = 0.14 ± 0.02, n = 11 without PIP2 and 
IRR/I = 0.17 ± 0.02, n = 12 with PIP2) (Fig. 3) and 
the TRPV1 antagonist capsazepine (CPZ; 10 μM) com-
pletely inhibited currents activated by 0.3 μM capsaicin 
with 10 μM DiC8-PIP2 (Fig. 3), indicating that the PIP2 
effects observed were mediated by TRPV1. These data 
indicate that PIP2 is a potentiator of TRPV1, a result 
not consistent with the PLC model of hyperalgesia (Fig. 
1, bottom left).
Previous experiments testing the effects of reducing 
the PIP2 concentration on TRPV1 used Xenopus oo-
cytes or HEK293 cells (Chuang et al., 2001). Because 
differences in expression system could potentially af-
fect the polarity of PIP2 modulation, we examined 
whether PIP2 potentiates or inhibits capsaicin-acti-
vated currents in the relevant native tissue. We applied 
PIP2 to patches from acutely dissociated mouse DRG 
neurons. In fi  ve out of seven patches, PIP2 did not in-
crease the capsaicin-activated current (Fig. 2 E, left; 
Figure 1.  Mechanism of NGF-mediated sensitization. Simplifi  ed 
cartoon representation of the TRPV1-PI3K-trkA signal transduc-
tion complex (above) and two models of NGF-mediated sensitiza-
tion (below). The PIP2 headgroups are shown in green and the 
PIP3 headgroups are shown in pink.  Stein et al. 513
the increases in the two other patches were less than 
twofold). We hypothesized that TRPV1 channels in our 
DRG neurons were already fully saturated with PIP2 
(perhaps because of their low expression levels), so 
that adding more PIP2 produced little or no additional 
potentiation. To test this hypothesis, we fi  rst applied 
polylysine to the patches to sequester endogenous 
PIP2. Our prediction is that if we fi  rst eliminate poten-
tiation of TRPV1 by endogenous PIP2, we should be 
able to restore the potentiation by adding PIP2 to the 
patches. As in patches from F-11 cells (Fig. 2 A), poly-
lysine treatment decreased the amplitude of the cap-
saicin-activated current in patches from DRG neurons 
(Fig. 2 E). We next added DiC8-PIP2 to the patch and 
found that the potentiation by PIP2 was restored (Fig. 
2 E, right; similar results were seen in three patches). 
Note that the current after PIP2 treatment was larger 
than observed with capsaicin initially. Our hypothesis 
predicted that the currents should have been equal. 
PIP2 has been reported to facilitate recovery of TRPV1 
from desensitization (Liu et al., 2005). It is possible 
that our application of PIP2 caused recovery of desen-
sitized channels in the patch, so that the total num-
ber of activatable channels increased. Other potential 
explanations include nonspecifi  c effects of polylysine 
and greater activity of DiC8-PIP2 compared with na-
tive PIP2. We conclude that PIP2 is not an inhibitor of 
TRPV1 channels but rather potentiates TRPV1 both in 
heterologous cells and in native DRG neurons, and is 
preassociated with TRPV1 in native cells. The potentia-
tion of TRPV1 by PIP2 invalidates the PLC model of 
NGF-mediated sensitization.
PI3K Interacts Directly with TRPV1
If NGF regulation of TRPV1 does not involve PLC hy-
drolysis of PIP2, then how does it occur? We hypoth-
esized that, like signaling in the Drosophila TRP/TRPL 
channels (Tsunoda and Zuker, 1999), signaling through 
TRPV1 could be mediated by a macromolecular signal 
transduction complex. To identify putative proteins that 
could bind to TRPV1 in such a complex, we performed 
a yeast 2-hybrid screen using the N-terminal region of 
TRPV1 as bait and a human fetal brain library as fi  sh. 
We found 38 candidate proteins (Table I). For one of 
these, the p85β subunit of PI3K (PI3K-p85β), we ob-
tained multiple isolates of two independent clones. To 
confi  rm the interaction between the N-terminal region 
of TRPV1 and PI3K-p85β, we performed a directed yeast 
2-hybrid assay. Mating of yeast strain AH109 containing 
GAL4BD-TRPV1-N1-432 (N terminus of TRPV1) with 
yeast strain Y187 containing GAL4AD-PI3K-p85β en-
abled the yeast to grow on selective medium requiring 
expression of the ade and his reporter genes. Growth 
of these yeast on selective medium confi  rmed the inter-
action between PI3K-p85β and the N-terminal region of 
TRPV1 in yeast.
Because the yeast 2-hybrid system can yield false-
positive results, we tested whether TRPV1 and PI3K-
p85β interact in mammalian cells. Our approach was 
Figure 2.  PIP2 is a potentiating molecule for TRPV1, not an in-
hibitory molecule. (A) Excised inside-out membrane patches 
were pulled from F-11 cells transfected with TRPV1. Points are 
steady-state currents recorded during a 100-ms pulse to +80 mV 
(positive inside relative to outside) from a holding potential of 0 mV. 
Zero current is indicated by the dotted line. Capsaicin and poly-
lysine (>300 kD) were applied for the duration of the bars. We 
chose 30 μg/ml polylysine because it has recently been shown to 
be effective in sequestering PIP2 from TRPM4 channels (Zhang 
et al., 2005b). Inhibition by polylysine did not spontaneously re-
verse over the time scale of our experiments, suggesting that its 
unbinding from the PIP2 is quite slow. (B) Currents and cells as 
in A. PIP2 (10 μM) and capsaicin were applied during the time of 
the bar. The delay observed between PIP2 application and the 
  increase in current arose from the special system we devised to 
apply very small amounts of the expensive phosphoinositide to 
our cell chamber (see Materials and methods). (C) Application of 
PIP2 to an untransfected F-11 cell. (D) Water-soluble DiC8-PIP2 
(red bar) reversibly potentiated capsaicin-activated current. In-
side-out excised patch from F-11 cell transfected with TRPV1. (E) 
Two representative inside-out patches from mouse DRG neurons. 
The open and fi  lled black bars as above. The red bar represents 
DiC8-PIP2. The time scale bar applies to both panels, but each 
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to use coimmunoprecipitation to test whether PI3K-
p85β physically interacts with TRPV1. We transfected 
HEK293 cells with TRPV1, either wild-type or with a 
FLAG epitope tag, lysed the cells, and precipitated with 
an anti-FLAG antibody. We then probed the blot with 
an antibody against PI3K-p85β. This approach relied 
on the cell producing endogenous PI3K-p85β in suf-
fi  cient quantity to interact with overexpressed TRPV1. 
As shown in Fig. 4 A (left lane), the anti-FLAG anti-
body precipitated a band of the appropriate size (85 
kD) recognized by the anti–PI3K-p85β antibody. This 
same band was observed when the anti–PI3K-p85 β 
antibody was used for both immunoprecipitation and 
immunoblotting (right lane). As a negative control, no 
PI3K-p85β was observed when non-FLAG tagged chan-
nels were used (center lane). We conclude from these 
experiments that TRPV1 and PI3K-p85β are physically 
associated in HEK293 cells.
Signaling in heterologous cells is subject to overex-
pression artifacts and other nonphysiological associa-
tions. To determine if TRPV1 and PI3K-p85β interact in 
native sensory neurons, it was necessary to test whether 
they could be coimmunoprecipitated from DRG neu-
rons. We homogenized mouse DRGs and used the anti–
PI3K-p85β antibody to immunoprecipitate the proteins. 
We then probed the blot with anti-TRPV1 to visualize 
TRPV1 that had been immunoprecipitated in the two 
cases. As shown in Fig. 4 B, the anti–PI3K-p85β antibody 
brought down TRPV1 (90 kD), indicating that PI3K-
p85β and TRPV1 are physically associated in native sen-
sory tissue.
We next sought to determine the region of PI3K-p85 
that interacts with TRPV1. The motivation for these ex-
periments arises from the known segregation of func-
tion in PI3K-p85. As shown in Fig. 5 A, PI3K-p85 has 
four types of functional domains: an SH3 domain 
(blue), a BCR domain for binding small GTP-binding 
proteins (green), proline-rich domains (purple), and 
SH2 domains (red). Each type of domain utilizes a dif-
ferent regulatory strategy. Identifying the region of 
PI3K-p85 that interacts with TRPV1 might therefore 
provide information essential to understanding how 
the interaction is regulated.
We performed in vitro interaction assays using TRPV1-
FLAG from HEK293 cell lysates immobilized on anti-
FLAG beads. We expressed full-length PI3K-p85α, as 
well as proteins corresponding to each of its functional 
domains, as GST fusion proteins in bacteria. The α and 
β isoforms of PI3K-p85 are 57% identical, with even 
higher identity within each functional domain. For 
these experiments we used the α subunit because it has 
been well studied as a GST fusion protein, and we found 
it to be soluble and largely monodispersed when exam-
ined with size exclusion chromatography (unpublished 
data). Each GST fusion protein was added to the immo-
bilized TRPV1, washed extensively, and the specifi  cally 
bound protein eluted with denaturing sample buffer. 
We then ran equivalent amounts of input and the bound 
protein on an SDS gel and performed Western blot 
analysis to determine the fraction of each that bound. 
As shown in Fig. 5 A, TRPV1 from HEK293 cell lysates 
bound to GST-p85α but not to GST. We next examined 
which region of PI3K-p85α was involved in the interac-
tion with TRPV1. We found that both SH2 domains 
(Fig. 5 A, red), but not the BCR domain (Fig. 5 A, 
green) or the SH3 domain (Fig. 5 A, blue), produced 
robust binding with full-length TRPV1. The yeast 2-hy-
brid screen that originally identifi   ed PI3K-p85 as a 
TRPV1 interaction partner identifi  ed two independent 
PI3K-p85 clones, whose locations are represented by 
the bars in Fig. 5. It is worth noting that these sequences 
overlap with the SH2 domains, further bolstering the 
conclusion that the PI3K-p85 SH2 domains mediate the 
interaction between PI3K and TRPV1.
Figure 3.  Ruthenium red (RR) and 
capsazepine (CPZ) reduce the am-
plitude of PIP2-potentiated currents. 
(A) Currents from inside-out excised 
patches in which the membrane was 
held and 0 mV and the potential was 
jumped to +80 mV, to −80 mV, and 
back to 0 mV. Note that RR is believed 
to be a voltage-dependent blocker of 
the pore, and thus is less effective at 
hyperpolarized potentials. In contrast, 
CPZ may allosterically inhibit activa-
tion, giving similar reductions in cur-
rent at depolarized and hyperpolarized 
potentials. RR (blue, top) and CPZ 
(red, bottom) were applied to different 
patches. (B) Box plot showing the per-
cent reduction in current at +80 mV 
for RR and CPZ. For comparison, the 
percent inhibition of capsaicin-activated currents by RR in the absence of PIP2 is shown (fi  rst box). Boxes enclose the 25th to 75th per-
centile of the data, lines within the boxes represent the median, and whiskers extend to the 10th and 90th percentiles.  Stein et al. 515
SH2 domains are common protein–protein interac-
tion domains that bind to phosphorylated tyrosines 
with high affi  nity (Vidal et al., 2001). Is tyrosine phos-
phorylation of TRPV1 required for TRPV1 to interact 
with PI3K-p85? To address this question we expressed 
TRPV1, trkA, and p75 (a neurotrophin receptor that 
complexes with trkA to regulate its function; Schor, 
2005) in HEK293 cells (as in Fig. 4 A). We immunopre-
cipitated with either anti-trkA or anti-TRPV1 antibodies 
and then used Western blot analysis to probe for trkA 
and TRPV1 to ensure their expression (Fig. 5 C, top). 
The membranes were then stripped and reprobed with 
an anti-phosphotyrosine antibody. As shown in Fig. 5 C 
(bottom), we found that trkA was tyrosine phosphory-
lated and that its phosphorylation was increased by 
NGF treatment (e.g., compare lanes 6 and 7). In con-
trast, TRPV1 was not recognized by the anti-phospho-
tyrosine antibody, without or with NGF treatment. We 
next tested whether recombinant TRPV1 could interact 
with PI3K-p85α in vitro. We used a FLAG-tagged N ter-
minus of TRPV1 (amino acids 1–432) expressed in bac-
teria and immobilized on anti-FLAG beads to pull down 
the recombinant PI3K-p85. We found binding similar to 
that observed using TRPV1 from HEK293 cells (Fig. 5 A), 
even though this protein derived from bacteria was 
not tyrosine phosphorylated (Fig. 5 B). Finally, we asked 
whether the effi   ciency of coimmunoprecipitation of 
TRPV1 and PI3K-p85β was altered by NGF (and, thus, 
potentially by tyrosine phosphorylation). We found no 
difference in the intensity of the TRPV1 band observed 
in anti-p85β antibody precipitates when we treated with 
NGF (Fig. 4 B). These experiments do not support a 
role for tyrosine phosphorylation in regulating the in-
teraction between TRPV1 and PI3K-p85 and argue for 
a persistent interaction between the two proteins rather 
than a transient one.
PI3K Activity Is Required for NGF-mediated Sensitization
Does the interaction between TRPV1 and PI3K repre-
sent a functional macromolecular signal transduction 
complex? It has been previously shown that wortman-
nin, a specifi  c inhibitor of PI3K, prevents NGF-medi-
ated sensitization of TRPV1 in calcium imaging 
experiments (Bonnington and McNaughton, 2003). We 
tested whether wortmannin would prevent the NGF-me-
diated increase in TRPV1 currents, thereby indicating 
that NGF signals through PI3K to regulate TRPV1. We 
used the perforated patch confi  guration of whole-cell 
voltage-clamp recording to measure currents in acutely 
dissociated mouse DRG neurons. This system allowed 
us electrical access to the cell’s interior and minimized 
dilution of the cellular contents. Further, using acutely 
dissociated neurons is expected to yield signal transduc-
tion similar to that observed in vivo. As shown in Fig. 6 
(A and D), capsaicin-activated currents were stable 
when examined at 10-min intervals. In contrast, a 10-
min incubation with NGF produced highly variable but 
signifi  cant increases in current (Fig. 6, B and D) that is 
the cellular correlate of sensitization in hyperalgesia. 
Incubating with NGF and 20 nM wortmannin for 10 
min did not produce an increase in the capsaicin-acti-
vated current (Fig. 6, C and D). The low concentration 
Figure 4.  Coimmunoprecipitation between TRPV1 and PI3K-p85β. 
(A) Immunoprecipitation from HEK293 cells transfected with 
  either TRPV1-FLAG or TRPV1, as a negative control. Proteins were 
immunoprecipitated with the indicated antibodies, and blots 
were probed with anti–PI3K-p85β antibody. (B) Immunoprecipita-
tion from mouse DRG cells. Proteins were immunoprecipitated with 
anti–PI3K-p85β, and blot was probed with anti-TRPV1 antibody.
TABLE I
Proteins Identifi  ed in Yeast 2-Hybrid Assay with N Terminus of TRPV1 
as Bait
Phosphoinositide-3-kinase 
 regulatory  subunit, 
  polypeptide 2 (PI3K-p85β)
Neuronatin
ADO37 protein NK2 transcription factor 
 homologue  B
BN51 temperature sensitivity 
 complementing  protein
Nuclear receptor coactivator 6 
 interacting  protein
Catenin, α2 Peroxisome biogenesis factor 10
Catenin, δ2 PL6
Calcium homeostasis ER protein 
 (CHERP)
PLAGL1
Contactin 1 PM5
CRK7 POLR2G
DAZ-associated protein 2 RAB26
Dynactin 1 RAN binding protein 9
GASC1 Ribosomal protein L12
General control of amino acid 
  synthesis 5-like-2 (GCN5)
SMA3
HELO Small glutamine-rich tetricopeptide 
  repeat (TPR)–containing protein 
 (SGT)
HIV-1 Tat interactive protein Snapin
HS1 binding protein Thrombospondin 3
ITM3 Ubiquitin-specifi  c protease 5
LOC90806 similar to RIKEN 
 cDNA  2610307121
VCY-interacting protein 1
Karyopherin, β1 Zinc fi  nger protein 151
Kinesin 2 +11 unidentifi  able proteins 
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of wortmannin used here has been shown to be specifi  c 
for PI3K (Ui et al., 1995). Thus, PI3K activity appears to 
be required for NGF-mediated sensitization of TRPV1.
NGF Increases the Number of TRPV1 Channels 
in the Plasma Membrane
An increase in capsaicin-activated current could arise 
from either potentiation of TRPV1 gating or an  increase 
in the number of active TRPV1 channels in the cell. To 
distinguish between these possibilities, we examined 
the effect of NGF on the capsaicin dose–response rela-
tion. In perforated-patch experiments, we measured 
currents activated by various concentrations of capsa-
icin before and after a 10-min incubation with NGF 
(Fig. 7 A). We measured the steady-state current at 
each concentration of capsaicin and constructed dose–
response relations (Fig. 7 B). NGF produced a signifi  -
cant increase in the magnitude of the maximal current 
(Fig. 7 C), with Imaxpost-NGF/Imaxpre-NGF = 1.28 (±0.07, 
n = 10). In contrast, we found that NGF did not change 
the EC50 for activation by capsaicin. The mean EC50 
value was 49.5 nM (±7.1 nM, n = 10) before NGF treat-
ment and 47.8 nM (±12.6 nM, n = 10) after NGF treat-
ment, and the mean ratio of EC50 values   before and 
after NGF for individual cells was 0.99 (±0.18, n = 10).
The observed increase in macroscopic current could 
arise from either an increase in unitary conductance 
or an increase in the number of active channels. We 
used nonstationary noise analysis to determine which 
of these parameters was affected by NGF. Fig. 8 A 
shows the increase in current as capsaicin was applied 
to an acutely dissociated DRG neuron in a perforated-
patch recording before (black) and after (red) treat-
ment with NGF. The time course refl  ects the perfusion 
time of our system as the concentration of capsaicin 
increased from 0 to 300 nM, a saturating concentra-
tion for these cells. We applied a smoothing function 
to determine the instantaneous mean current at each 
point, and subtracted the smoothed trace to extract 
the noise (Fig. 8 B). We then plotted the variance of 
Figure 5.  TRPV1 binds to the 
PI3K SH2 domains in a phos-
photyrosine-independent man-
ner. (A) In vitro interaction assay 
using TRPV1-FLAG from 
HEK293 cells (left) or recombi-
nant N terminus of TRPV1 from 
bacteria with a FLAG epitope at 
its C-terminal end (right). FLAG-
tagged TRPV1 protein was im-
mobilized on anti-FLAG agarose 
beads, and recombinant GST fu-
sion proteins corresponding to 
PI3K-p85α were tested for inter-
action. The bars in the cartoon 
represent the two independent 
clones of PI3K-p85β identifi  ed 
in the yeast 2-hybrid assay. For 
the Western blot, equivalent 
amounts of input and bound 
proteins were probed with anti-
GST antibody. (B) The recombi-
nant N-terminal protein was not 
tyrosine phosphorylated. The re-
combinant FLAG-tagged protein 
was run in the left lane, and 
  lysates from trkA-transfected 
HEK293 cells were run in the 
right lane. Duplicate gels were 
run, and Western blot analysis 
was then performed with either 
the anti-FLAG antibody (top) or 
the anti-phosphotyrosine anti-
body (bottom). (C) TRPV1 in 
HEK293 cells was not tyrosine 
phosphorylated. HEK293 cells 
expressing combinations of 
TRPV1, p75, and trkA, as indicated in the fi  gure, were treated with either NGF or vehicle and then immunoprecipitated with anti-trkA 
(lanes 1–7) or anti-TRPV1 (lanes 8–13) antibodies. Lanes 1–7 were separated from lanes 8–13 and the membranes were probed with 
anti-trkA antibody and anti-TRPV1 antibody, respectively (top). Segments of the membrane were then reapposed for imaging. The 
membranes were then stripped and reprobed with anti-phosphotyrosine antibody (bottom).  Stein et al. 517
the noise versus instantaneous mean current (Fig. 8 
C) and fi  tted the data with a parabola with the unitary 
conductance (i) and number of channels (N) as free 
parameters (see Materials and methods). The analysis 
revealed an increase in the number of channels, with-
out a change in either unitary conductance or calcu-
lated open probability (Fig. 8 D). The increase in N 
(Npost-NGF/Npre-NGF = 1.23 ± 0.07; n = 10) was compa-
rable in magnitude to the increase in current seen in 
Fig. 7 C. Our data indicate that NGF sensitizes TRPV1 
through an increase in the number of active channels 
in the plasma membrane.
Did NGF activate channels that were already in the 
membrane but quiescent or increase the total number 
of channels in the plasma membrane? We used TIRF 
microscopy to address this question. In TIRF, an expo-
nentially decaying evanescent fi   eld allows excitation 
of fl  uorescent molecules within  100 nm of the cov-
erslip (Axelrod, 2001; Steyer and Almers, 2001). Thus, 
TIRF microscopy can be used to image plasma mem-
brane–associated fl   uorescent channels with minimal 
contamination from the cytoplasm. Using enhanced 
YFP fused to TRPV1 (TRPV1-eYFP) expressed in F-11 
cells, we performed perforated patch electrophysiology 
experiments simultaneous with TIRF recordings. The 
two different ways in which NGF could increase channel 
activity make different predictions about NGF-induced 
changes in fl   uorescence. If NGF activates quiescent 
channels in the membrane, the amplitude of the capsa-
icin-activated current is expected to increase without an 
increase in the total number of channels present in the 
plasma membrane. In this scenario, NGF would lead to 
an increase in capsaicin-activated current without an 
accompanying increase in TRPV1-associated fl  uores-
cence in the membrane. In contrast, if NGF causes a 
net increase in the number of channels in the plasma 
membrane, then an increase in TRPV1-associated fl  uo-
rescence should be observed that is proportional to the 
increase in current.
Fig. 9 C shows a set of TIRF images and membrane 
currents simultaneously recorded from a represen-
tative cell under control conditions (left) and upon 
application of 100 nM capsaicin before (center) and 
after (right) a 10-min incubation with NGF (100 ng/ml). 
For these experiments, cells were imaged using iden-
tical laser power and camera gain. Changes in fl  uo-
rescence intensity therefore refl  ect changes in light 
emission and not changes in excitation intensity or 
photon collection effi  ciency. As expected, superfusion 
of a solution containing 100 nM capsaicin increased 
the amplitude of TRPV1 currents. This increase in the 
amplitude of the currents occurred in the absence of a 
change in membrane-associated TRPV1-eYFP fl  uores-
cence (Fig. 9 C, center, and Fig. 9 D, white bar). Inter-
estingly, incubation with NGF for 10 min increased the 
magnitude of the capsaicin-sensitive TRPV1 current 
and TRPV1-eYFP fl  uorescence  (P  < 0.05). Indeed, 
NGF increased membrane-associated TRPV1-eYFP fl  u-
orescence (Ffi  nal/Finitial post-NGF = 1.3 ± 0.1, n = 5; 
Fig. 9 D, red bar) and TRPV1 currents (1.3 ± 0.1, n = 4) 
to a similar extent.
The increase in TRPV1-eYFP fl  uorescence observed 
after NGF treatment occurred in the absence of any 
measurable changes in cell morphology, indicating 
that the increase in fl  uorescence was not due to a ma-
jor reorganization of the amount of membrane within 
the evanescent fi   eld. Furthermore, an increase in 
TRPV1-eYFP fl  uorescence was never observed in F-11 
cells expressing TRPV1-eYFP, but that were not treated 
with NGF (Ffi  nal/Finitial post-vehicle = 1.0 ± 0.1, n = 5; 
see Fig. 8 A). These data exclude the possibility that a 
time-dependent, NGF-independent mechanism could 
underlie the increase in TRPV1-eYFP fl  uorescence de-
scribed above. In fact, TRPV1-eYFP fl  uorescence was 
Figure 6.  Wortmannin inhibits NGF-mediated 
sensitization of TRPV1. (A–C) Perforated patch 
recordings from acutely dissociated mouse DRG 
neurons activated with 25 nM capsaicin and held 
at −80 mV. Either (A) no drug, (B) 100 ng/ml 
NGF, or (C) NGF plus 20 nM wortmannin (WMN) 
were applied for 10 min. (D) The ratio of fi  nal 
current to initial current for the three conditions. 
The mean is shown as a horizontal line. The me-
dian for these cells was 1.16, 2.99, and 1.05 for 
control, NGF, and NGF + WMN, respectively.518 PI3K-TRPV1 Complex Mediates NGF Sensitization
  remarkably stable through the progression (10–15 min) 
of the experiment in the absence of NGF stimulation 
(Fig. 9 B). We conclude that the NGF-induced increase 
in TRPV1 current was produced by an increase in the 
number of functional TRPV1-eYFP channels in the 
plasma membrane.
DISCUSSION
Thermal hyperalgesia is known to involve an increase in 
TRPV1 activity (Shu and Mendell, 1999a,b; Chuang et al., 
2001), but the mechanism of this increase is controver-
sial. NGF activation of trkA has been proposed to acti-
vate PLC, which hydrolyzes PIP2, relieving inhibition of 
Figure 7.  NGF increases the maximum current but 
not the EC50 for capsaicin. (A) Whole cell currents 
from acutely dissociated mouse DRG neurons in re-
sponse to various concentrations of capsaicin before 
and after a 10-min treatment with 100 ng/ml NGF. 
(B) Dose–response relation for cell in A. Solid curves 
are fi  ts with the Hill equation, with a slope of 3. 
(C) Ratio of maximal currents after 10 min NGF 
treatment or 10 min control treatment. Asterisk repre-
sents a statistically signifi  cant difference compared 
with control. (Imaxpost-NGF/ImaxpreNGF = 1.28 ± 0.22; 
n = 10).
Figure 8.  NGF increases the number 
of functional TRPV1 channels and does 
not change the channel open probabil-
ity or unitary conductance. (A) Cur-
rents recorded in perforated patch 
whole cell voltage clamp (−80 mV) 
were recorded from DRG neurons 
while they were perfused with saturat-
ing capsaicin before (black) and after 
(red) treatment with NGF (100 ng/ml, 
10 min). (B) Smoothed functions of 
the mean were subtracted from the raw 
current traces, generating a plot of vari-
ance versus time (C). The variance was 
calculated for segments of data, with 
the length of the segments reduced 
  until the variance reached a minimum. 
The variance was plotted versus the 
smoothed function of the mean and fi  t-
ted with the equation f(x) = xi − (x2)/
N using a least squares algorithm. (D) 
The fi   ts revealed an increase in the 
number of functional channels (N) af-
ter NGF, but no difference in i. The ab-
solute value of N was calculated to be 
1782 before NGF and 2577 after NGF 
treatment. The Po was calculated from 
the capsaicin response current with the 
equation Po = I/(Ni). The Po in satu-
rating capsaicin was not found to have 
been affected by NGF.  Stein et al. 519
TRPV1 (Fig. 1, bottom left). Three aspects of our work 
are novel and require reformulation of this model: (1) 
we found that PIP2 potentiated TRPV1 instead of inhib-
iting it as predicted by the PLC model; (2) PI3K-p85β 
was physically and functionally coupled with TRPV1 in a 
signal transduction complex; and (3) we observed real-
time translocation of fl  uorescent TRPV1 to the mem-
brane upon stimulation by NGF. Based on this evidence, 
we propose that NGF acts through the PI3K pathway, 
and not through PLC, to facilitate TRPV1 traffi  cking to 
the plasma membrane and hence increase TRPV1 func-
tion during hyperalgesia.
A summary of our model is shown in Fig. 1. Here, 
TRPV1, PI3K, and trkA physically interact in a signal 
transduction complex (Fig. 1, top). We have included 
trkA because it has been shown to coimmunoprecipitate 
with TRPV1 from transfected HEK293 cells (Chuang 
et al., 2001), a phenomenon we observed as well (unpub-
lished data). Activation of trkA by NGF would facilitate 
traffi  cking of TRPV1 to the plasma membrane, increasing 
channel current (Fig. 9).
Our data are generally consistent with recent work 
from Zhang et al. (2005a). They show that PI3K inhibi-
tors decrease the number of NGF-sensitive cells, that 
NGF-treated cells have more TRPV1 present at the sur-
face than untreated cells, and that tyrosine phosphory-
lation of TRPV1 by Src kinase is in the pathway between 
trkA and TRPV1. Although tyrosine phosphorylation of 
TRPV1 was not required for its binding to PI3K-p85 and 
TRPV1 did not appear to be tyrosine phosphorylated in 
our system, phosphorylation of TRPV1 makes an attrac-
tive component of a system designed to increase TRPV1 
traffi  cking to the plasma membrane. Does phosphoryla-
tion of plasma membrane TRPV1 increase its lifetime? 
Does it help target new channels to regions of the cell 
that already contain channels? Alternatively, phosphor-
ylation of TRPV1 present in intracellular membrane 
compartments may be required for their translocation 
to or insertion in the plasma membrane. It is clear that 
much work remains to elucidate the mechanism by 
which NGF signaling increases the number of TRPV1 
channels in the plasma membrane.
Here we show that PIP2 promotes TRPV1 activation 
but also that PI3K, an enzyme that converts PIP2 to 
PIP3, promotes TRPV1 activation. Although it would be 
more parsimonious if regulation by PIP2 and by PI3K 
Figure 9.  NGF increased the 
number of channels in the 
plasma membrane. TIRF im-
ages and perforated patch 
whole cell voltage clamp cur-
rents from F-11 cells trans-
fected with TRPV1-eYFP, trkA, 
and p75. (A) The fl  uores-
cence in the plasma mem-
brane is not altered under 
control conditions. TIRF im-
ages taken from a representa-
tive cell immediately after 
attaining maximum perfora-
tion (left), during the addi-
tion of capsaicin (100 nM; 
center), and during a second 
exposure to capsaicin (right), 
which followed a 10-min per-
fusion with vehicle (no NGF). 
(B) Time course of the spa-
tially averaged fl  uorescence 
intensity from control experi-
ments (no NGF). Fluores-
cence values were normalized 
to the initial mean fl  uores-
cence intensity of each cell. 
The data represent mean ± 
SEM from fi  ve  independent 
experiments. (C) Fluorescence in the plasma membrane increases in response to NGF. TIRF images from a typical F-11 cell after patching 
(left), during superfusion of capsaicin (center), and during superfusion of capsaicin after stimulation with 100 ng/ml NGF (right) for 10 
min. Note that the only difference between the protocol shown on C and A was the addition of NGF. The capsaicin-activated currents corre-
spond to the imaged cell, before (black trace) and after (red trace) NGF treatment. (D) Bar plot of the normalized membrane fl  uorescence 
before (white bar) and after (red bar) a 10-min NGF treatment (100 ng/ml). The white bar represents the fl  uorescence intensity observed 
during the fi  rst capsaicin response (before NGF) normalized to the initial fl  uorescence. The asterisk represents a statistically signifi  cant dif-
ference (P < 0.05) compared with capsaicin-induced changes pre-NGF treatment (Ffi  nal/Finitial pre-NGF = 0.98 ± 0.03, Ffi  nal/Finitial post-NGF = 
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worked via the same mechanism, we do not believe this 
is the case. Nonstationary noise analysis and TIRF mi-
croscopy both indicate that PI3K acts by increasing the 
number of TRPV1 channels in the plasma membrane. 
From the increase in fl  uorescence in TIRF experiments, 
we believe that the new channels are translocated from 
beyond TIRF range (100 nm). This translocation mech-
anism is not likely to be preserved in the excised patch 
system in which PIP2 potentiation is observed, would 
not explain how sequestration of PIP2 by polylysine in-
hibited TRPV1 in excised patches, and would not be ex-
pected to be reversed upon washing of DiC8-PIP2 from 
the bath. We conclude that PIP2 is required for TRPV1 
activity, but that the association of PIP2 with TRPV1 is 
not involved in hyperalgesia. It has been proposed that 
synthesis of PIP2 is required for recovery from desensi-
tization, with the implication that desensitization of 
TRPV1 could involve hydrolysis of PIP2 (Liu et al., 
2005). The PIP2 potentiation we observed is consistent 
with such a function. Hyperalgesia, however, would in-
volve a distinct, PI3K-mediated traffi  cking of TRPV1 to 
the plasma membrane.
How do we know that the PIP2-activated current is 
mediated by TRPV1? Four types of experiments, al-
though indirect, together indicate that this is the case. 
First, PIP2 dramatically potentiated activation of the 
current by the TRPV1 agonist capsaicin (Fig. 2 B). Sec-
ond, no effect of PIP2 was observed in untransfected 
cells (Fig. 2 C). Third, the potentiating properties of 
PIP2 were observed in both heterologous cells and DRG 
neurons (Fig. 2, B and E). Finally, the TRPV1 antago-
nist CPZ completely inhibited currents activated by cap-
saicin with PIP2, and the nonspecifi   c TRP channel 
blocker RR blocked the same fraction of the capsaicin-
activated current in the absence and presence of PIP2. 
Thus, although we cannot defi  nitively exclude the pos-
sibility that a channel other than TRPV1 was the target 
of PIP2 potentiation, we see no evidence that PIP2 in-
hibits TRPV1 as predicted by the PLC model of NGF-
mediated sensitization.
PIP2 produced a very large increase in the capsaicin-
activated current when TRPV1 was overexpressed in 
F-11 cells. Given that the open probability of the chan-
nels is near 1 at saturating concentrations of capsaicin 
(Premkumar et al., 2002; Hui et al., 2003; Rosenbaum 
et al., 2004), this must represent primarily an increase 
in the number of active channels. These data argue that 
the vast majority of the channels present in the plasma 
membrane must be quiescent. In contrast, patches from 
DRG neurons were not typically potentiated by PIP2 un-
less fi  rst pretreated with polylysine. These data suggest 
that overexpression of TRPV1 in F-11 cells outstripped 
the supply of phosphoinositide, so that there was not 
enough phosphoinositide available for the large num-
ber of channels present. The lower expression level in 
DRG neurons allowed most or all of the channels to be 
preassociated with PIP2, so that a pool of PIP2-less 
TRPV1 was not available until the PIP2 had been re-
moved from the channels by polylysine.
PIP2 is a required cofactor for activation of many 
types of channels. The phosphoinositide modulation of 
TRPV1 is consistent in many respects with PIP2 modula-
tion of Kir channels, KCNQ channels, TASK and TREK 
channels, and several TRP channels (Suh and Hille, 
2005). In many cases, PIP2 regulation is dynamically 
controlled by GPCRs and RTKs coupled to PLC. Brady-
kinin mediates infl  ammatory hyperalgesia through the 
B2 GPCR. Although this effect has been proposed to 
work via a PLC-induced decrease in PIP2, relieving 
PIP2-mediated channel inhibition, our results are not 
consistent with such a mechanism. We suggest that 
TRPV1 sensitization by bradykinin is due to PLC gener-
ation of diacylglycerol (DAG), and DAG activation of 
PKC, a mechanism known to sensitize TRPV1 (Cesare 
and McNaughton, 1996; Cesare et al., 1999; Premkumar 
and Ahern, 2000; Vellani et al., 2001; Numazaki et al., 
2002; Bhave et al., 2003; Bolcskei et al., 2005; Ferreira 
et al., 2005; Lee et al., 2005). Further evidence for distinct 
mechanisms for NGF- and bradykinin-mediated sensiti-
zation comes from experiments showing that although 
bradykinin sensitizes TRPV1 in both adult and neonatal 
DRG neurons, neurons from early postnatal animals are 
not sensitized by NGF (Zhu et al., 2004). Finally, muta-
tion of the TRPV1 residues believed to be phosphory-
lated by PKC upon bradykinin stimulation does not 
alter NGF-mediated sensitization (Zhang et al., 2005a).
The SH2 domains of PI3K-p85 were suffi  cient to me-
diate its interaction with TRPV1, raising the possibility 
that PI3K-p85 binds to a phosphorylated tyrosine on 
TRPV1. Work from McNaughton and colleagues (Zhang 
et al., 2005a) is consistent with this idea. They found 
that NGF activation of PI3K leads to activation of Src ki-
nase and that this activation was associated with sensiti-
zation. Furthermore, phosphorylation of a tyrosine in 
the N-terminal region of TRPV1 (Y200) by Src was 
linked with increased surface expression of TRPV1. Al-
though we did not observe tyrosine phosphorylation of 
TRPV1 under our experimental conditions, and do not 
believe it is required for PI3K-p85 binding, we cannot 
rule out that tyrosine phosphorylation of TRPV1 may 
be important for NGF-mediated sensitization.
The agreement between the magnitude of increases 
in fl  uorescence and current in our TIRF/electrophysi-
ology recordings is remarkable. Although at least 10 
times slower than the “rapid vesicular insertion of TRP” 
reported for TRPC5 channels (Bezzerides et al., 2004), 
the mechanism of NGF facilitation of TRPV1 traffi  cking 
may be similar to the mechanism of EGF facilitation of 
TRPC5 traffi  cking. A major difference, however, lies in 
the physical coupling of PI3K and TRPV1. What is the 
purpose of this coupling? The raison d’être for this sig-
nal transduction complex may be to confer spatial or   Stein et al. 521
temporal specifi  city. In any case, it seems likely that cou-
pling between ion channels and enzymes that control 
their traffi  cking is a theme that may be repeated in 
other systems.
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